Chemoinformaics analysis of PALMITOLEIC-ACID-ESTER
| Molecular Weight | 302.458 | nRot | 2 |
| Heavy Atom Molecular Weight | 272.218 | nRig | 17 |
| Exact Molecular Weight | 302.225 | nRing | 3 |
| Solubility: LogS | -4.588 | nHRing | 0 |
| Solubility: LogP | 4.578 | No. of Aliphatic Rings | 3 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 55.0078 |
| nHD | 1 | BPOL | 30.9642 |
| QED | 0.746 |
| Synth | 4.119 |
| Natural Product Likeliness | 2.955 |
| NR-PPAR-gamma | 0.827 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.067 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -5.118 |
| MDCK | 0.0000166 |
| BBB | 0.036 |
| PPB | 0.954024 |
| VDSS | 0.686 |
| FU | 0.0233823 |
| CYP1A2-inh | 0.038 |
| CYP1A2-sub | 0.803 |
| CYP2c19-inh | 0.041 |
| CYP2c19-sub | 0.932 |
| CYP2c9-inh | 0.172 |
| CYP2c9-sub | 0.475 |
| CYP2d6-inh | 0.063 |
| CYP2d6-sub | 0.296 |
| CYP3a4-inh | 0.189 |
| CYP3a4-sub | 0.617 |
| CL | 0.499 |
| T12 | 0.293 |
| hERG | 0.002 |
| Ames | 0.016 |
| ROA | 0.04 |
| SkinSen | 0.73 |
| Carcinogencity | 0.668 |
| EI | 0.638 |
| Respiratory | 0.829 |
| NR-Aromatase | 0.423 |
| Antiviral | No |
| Prediction | 0.680023 |